Allianz Asset Management GmbH - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 341 filers reported holding NEKTAR THERAPEUTICS in Q2 2019. The put-call ratio across all filers is 2.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2023$143,697
-55.6%
204,434
+42.9%
0.00%
-100.0%
Q4 2022$323,322
-64.5%
143,063
+113.3%
0.00%0.0%
Q4 2021$910,000
+145.3%
67,060
+224.4%
0.00%
Q3 2021$371,000
-15.9%
20,670
-19.5%
0.00%
Q2 2021$441,000
-14.0%
25,6700.0%0.00%
Q1 2021$513,000
+18.5%
25,670
-1.7%
0.00%
-100.0%
Q3 2020$433,000
-41.2%
26,115
-18.0%
0.00%0.0%
Q2 2020$737,000
+10.2%
31,832
-15.0%
0.00%0.0%
Q1 2020$669,000
-45.9%
37,458
-34.6%
0.00%0.0%
Q4 2019$1,236,000
+485.8%
57,237
+393.3%
0.00%
Q3 2019$211,000
-84.5%
11,603
-69.7%
0.00%
-100.0%
Q2 2019$1,361,000
+1.6%
38,250
-4.0%
0.00%0.0%
Q1 2019$1,339,000
+13.3%
39,840
+11.3%
0.00%0.0%
Q4 2018$1,182,000
-39.2%
35,790
-10.1%
0.00%
-50.0%
Q2 2018$1,944,000
-82.4%
39,798
-61.6%
0.00%
-81.8%
Q1 2018$11,018,000
+99.5%
103,684
+12.1%
0.01%
+175.0%
Q4 2017$5,523,000
+112.3%
92,471
-14.7%
0.00%
+100.0%
Q3 2017$2,602,000
+33.0%
108,409
+7.4%
0.00%0.0%
Q2 2017$1,956,000
-29.7%
100,902
-15.4%
0.00%
-33.3%
Q1 2017$2,784,000
+104.0%
119,200
+7.2%
0.00%
+200.0%
Q4 2016$1,365,000
-59.3%
111,217
-43.7%
0.00%
-66.7%
Q3 2016$3,351,000
+12.8%
197,702
-5.4%
0.00%0.0%
Q2 2016$2,972,000
+3.5%
208,9020.0%0.00%0.0%
Q1 2016$2,872,000
-18.5%
208,902
+1.2%
0.00%
-25.0%
Q4 2015$3,522,000
+55.8%
206,3700.0%0.00%
+33.3%
Q3 2015$2,261,000
-12.4%
206,3700.0%0.00%0.0%
Q2 2015$2,582,000
-69.6%
206,370
-73.3%
0.00%
-70.0%
Q1 2015$8,495,000
-28.0%
772,309
+1.5%
0.01%
-23.1%
Q4 2014$11,794,000
+17.2%
760,891
-8.7%
0.01%
+8.3%
Q3 2014$10,062,000
+1.4%
833,660
+7.7%
0.01%0.0%
Q2 2014$9,920,000
-3.4%
773,833
-8.6%
0.01%0.0%
Q1 2014$10,266,000
+23.4%
846,986
+15.5%
0.01%
+9.1%
Q4 2013$8,322,000
-25.7%
733,196
-31.6%
0.01%
-26.7%
Q3 2013$11,201,000
+77.3%
1,071,950
+96.0%
0.02%
+66.7%
Q2 2013$6,317,000546,9000.01%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q2 2019
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,828,400$89,281,0006.61%
Cormorant Asset Management, LP 1,500,000$73,245,0005.42%
Camber Capital Management LP 2,000,000$97,660,0003.76%
Rhenman & Partners Asset Management AB 617,652$30,160,0003.09%
BRIDGER MANAGEMENT, LLC 1,134,414$55,393,0003.00%
First Light Asset Management, LLC 374,251$18,275,0002.84%
Gs Investments, Inc. 54,000$2,636,820,0001.97%
SABBY MANAGEMENT, LLC 241,922$11,813,0001.82%
QUANTRES ASSET MANAGEMENT Ltd 50,000$2,441,0001.41%
Tibra Equities Europe Ltd 173,183$8,457,0001.27%
View complete list of NEKTAR THERAPEUTICS shareholders